Infection Control Related News
Health Europa Quarterly Issue 19
Welcome to Health Europa Quarterly Issue 19, which comprehensively investigates the current health landscape, from combatting COVID-19 and tackling healthcare inequalities to women’s health...
Exploring how natural killer cells can enhance wound healing
Christian Stockmann, Assistant Professor at the University of Zurich, outlines his recent research into natural killer cells and how these cells can be harnessed...
Uncovering why the COVID-19 Delta Variant is exceptionally infectious
Research emerging from the United States has revealed what makes the dreaded COVID-19 Delta Variant so infectious, a breakthrough that may help to design...
How can we alleviate the burden of antibiotic resistance?
Professor Colin Garner, CEO of charity Antibiotic Research UK, discusses how enhancing knowledge can help to mitigate antibiotic resistance.
Antibiotic resistance is a growing public...
Why sepsis awareness matters in the fight to save lives
With early diagnosis being vital in the treatment of sepsis, Sepsis Alliance shares how they are working to raise awareness of the condition’s associated...
COVID-19 antibodies significantly boosted in double vaccinated individuals
A study conducted in Sweden has elucidated that although COVID-19 antibodies are reduced in the airways following SARS-CoV-2 infection, two vaccine doses increase these...
Medical professionals urge the public to get the influenza vaccine
A plethora of critical care and pulmonary societies are advising the public to receive the influenza vaccine as we edge closer to the flu...
Forecasting COVID-19 hospitalisations and deaths with cell discovery
A team of scientists has made a novel cell discovery that may be able to predict the probability of COVID-19 hospitalisations and deaths.
The University...
Cutting-edge face shield destroys SARS-CoV-2 and multi-resistant bacteria
A team of researchers based in Spain have developed an innovative face shield that effectively deactivates SARS-CoV-2 and multi-resistant bacteria.
The groundbreaking face shield technology...
Innovative model predicts COVID-19 infection risk in the workplace
A collaboration of UK scientists have developed a cutting-edge predictive model that can accurately assess the risk of COVID-19 infection in office and school...
UVC: Examining the efficacy of the emerging disinfection technology
Gabriele Messina and Gabriele Cevenini of the University of Siena explore the emergence and efficacy of UVC disinfection technologies.
The onset of the COVID-19 pandemic...
Pfizer COVID vaccine demonstrates excellent efficacy against all variants
A novel study has revealed that two doses of the Pfizer COVID vaccine achieve 90% effectiveness against hospitalisations for at least six months against...
UK award substantial funding to safeguard adult social care this winter
The UK government has revealed that it will be providing considerable funding to support the adult social care sector throughout winter, a particularly challenging...
Exploring the issues surrounding vaccinating children against COVID-19
As the US and many European countries start vaccinating children against COVID-19, should more be done to prioritise those beyond our borders? Dominic Wilkinson,...
Shedding light on the world of UVC disinfection technologies
Tristan Williams, Technical Director of Finsen Tech Group outlines key aspects to consider when purchasing UVC disinfectant products.
Tristan Williams, Technical Director of Finsen Tech...
Effectively mitigating the impacts of mucormycosis
Martin Hoenigl, the President of the European Confederation of Medical Mycology, discusses the challenges of diagnosing and treating mucormycosis.
Mucormycosis is perhaps not a term...
Harnessing the benefits of UVA light treatment in COVID-19 patients
Following a first-in-human study which analysed the efficacy of UVA light treatment in COVID-19 patients, Health Europa spoke to Dr Ali Rezaie from the academic healthcare organisation, Cedars-Sinai, to find out more.
Nova Biologicals: Infection prevention during the winter period
Microbiological testing specialist Nova Biologicals outlines the key infection prevention measures to keep in mind this festive season.
The celebration of holidays is one of...
Trial begins for world-first multivariant COVID-19 vaccine booster
A phase one trial for the world’s first multivariant COVID-19 booster vaccine has been launched in Manchester.
Initiated by pharmaceutical company Gritstone, in partnership with...
ASAP Innovations: Pioneers of the personal protective equipment industry
As the COVID-19 crisis has evolved and the pandemic has just about taken its toll on almost every sector across the globe, those working...